Tsuruha Holdings Inc. (3391.T): PESTEL Analysis

Tsuruha Holdings Inc. (3391.T): PESTLE Analysis [Dec-2025 Updated]

JP | Healthcare | Medical - Pharmaceuticals | JPX
Tsuruha Holdings Inc. (3391.T): PESTEL Analysis

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Tsuruha Holdings Inc. (3391.T) Bundle

Get Full Bundle:
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$25 $15
$9 $7
$9 $7
$9 $7

TOTAL:

Tsuruha sits at a strategic inflection point: a dominant domestic footprint, fast-moving digital and AI upgrades, and a growing "silver market" give it clear strengths and growth levers, while rising labor and compliance costs, higher interest burdens from recent M&A, and tighter medical fee policies expose operational vulnerabilities; the Aeon-Welcia tie-up, e‑commerce and telemedicine expansions, and ESG/sustainable sourcing offer high-impact opportunities - but currency volatility, inflation, regulatory pressure and climate risks threaten margins and asset resilience, making the company's next execution moves critical for preserving market leadership.

Tsuruha Holdings Inc. (3391.T) - PESTLE Analysis: Political

Healthcare policy in Japan links government reimbursement and fee schedules to high-performance pharmacy functions, creating direct revenue incentives for pharmacies that deliver advanced clinical services. Since the 2016 revision of the medical fee schedule and subsequent annual adjustments, pharmacies demonstrating medication adherence support, polypharmacy management and home care coordination qualify for premium fees. For a large chain like Tsuruha, this translates into potential fee uplifts of 3-8% per qualifying prescription mix and contributes to EBITDA margin improvements when clinical services scale across >2,000 stores.

Key metrics:

  • Premium fee uplift for certified pharmacy functions: 3-8% (per ministry guidelines)
  • Target share of prescriptions eligible for performance fees: 20-35%
  • Estimated incremental annual revenue per qualifying store: JPY 2-6 million

Generic drug penetration targets are central to national cost containment programs. The Ministry of Health, Labour and Welfare (MHLW) has set progressive generic substitution targets - reaching national utilization rates of ~80% in recent years - which reduce margins on branded dispensing but increase volume. For Tsuruha, higher generic penetration compresses gross profit per unit for some SKUs but permits larger prescription throughput and strengthens procurement negotiation leverage.

Relevant figures:

Metric Value Implication for Tsuruha
National generic utilization rate (2023) ~80% Higher volume, lower per-unit margin, reliance on scale
MHLW target (short-term) Increase to 82-85% by 2025 Accelerated substitution policies; procurement strategy critical
Gross margin impact Estimated -0.5 to -1.5 p.p. without cost offsets Necessitates efficiency or service premium capture

Merger and acquisition activity must align with government visions for efficient, integrated healthcare providers. The government supports consolidation that enhances community-based care and reduces hospital readmissions; regulatory reviews prioritize continuity of care and patient safety. Tsuruha's M&A strategy to acquire smaller pharmacy groups and integrate them into closed-loop dispensing and home-care services can receive favorable regulatory treatment, but transactions exceeding certain market-share thresholds invite closer scrutiny by competition and healthcare regulators.

M&A considerations:

  • Regulatory approval: increased scrutiny when local market share >30%
  • Expected post-merger integration timeline to meet government standards: 12-24 months
  • Potential public funding or pilot program support for integrated care models: JPY 100-500 million per regional pilot

Regional trade pacts in Asia-Pacific (e.g., CPTPP, RCEP) enable cross-border retail and procurement efficiencies. Tariff reductions, harmonized standards and streamlined customs procedures reduce cost for imported OTC products and health supplies. For Tsuruha, this lowers imported SKU landed costs by an estimated 2-6% depending on product category and origin, supporting competitive pricing in inbound tourists' segments and potential regional store rollouts.

Agreement Key benefit Estimated cost impact
CPTPP Regulatory harmonization, IP protections -2% to -4% landed cost for selected OTC imports
RCEP Lower tariffs, simplified rules of origin -1% to -6% landed cost depending on category
ASEAN bilateral accords Faster customs, e-invoicing frameworks -0.5% to -2% logistics cost

Digital infrastructure security and national data sovereignty policies increase compliance burdens and related costs. Japan's revisions to data protection and cross-border data transfer frameworks require stricter patient data handling, on-premises storage or approved transfer mechanisms. For a retailer with integrated POS, pharmacy dispensing records and telehealth linkage, compliance costs include encryption, secure cloud certifications, audits and potential localization - estimated at JPY 200-800 million in upfront IT investments and JPY 50-150 million annually for maintenance and compliance for a large-scale deployment.

  • Estimated one-time compliance IT spend: JPY 200-800 million
  • Estimated annual incremental compliance OPEX: JPY 50-150 million
  • Potential penalties for data breaches: up to JPY 100 million+ and reputational loss

Tsuruha Holdings Inc. (3391.T) - PESTLE Analysis: Economic

Rising interest rates increase debt servicing and import costs. Between 2022-2024 global central bank tightening and gradual normalization of Japanese yields have pushed short-term borrowing costs from negative/near-zero toward positive territory (approx. 0.0%-0.5% for short-term JPY rates in 2023-24). For a retail operator with store-level financing and corporate borrowings, a 100 basis-point rise in rates typically increases annual interest expense materially - for example, a notional JPY 30 billion gross interest-bearing liability would see incremental interest cost of roughly JPY 300 million per year. Higher global rates also increase the cost of USD- or EUR-denominated import financing and letters of credit for imported pharmaceutical raw materials and cosmetics.

Inflation erodes real wages and shifts demand to private labels. Consumer price inflation in Japan moved from near 0% historically to roughly 2%-3% CPI year-on-year in 2023-24, while food and daily living goods saw higher volatility. Rising consumer prices compress discretionary spending and encourage migration to lower-margin private-label and promotion-driven SKUs. Lower-income cohorts reduce basket size; average basket value can decline even as transaction frequency stays stable, pressuring gross margins.

Modest GDP growth limits organic store expansion. Japan's GDP growth has been modest, in the range of ~0.5%-1.5% annually in the recent post-pandemic period (2022-2024). Slower macro expansion constrains same-store-sales uplift and increases unit economics pressure for new stores. Expansion plans therefore prioritize high-density urban locations, store format optimization, and M&A over large-scale greenfield rollouts to preserve return-on-invested-capital.

Labor costs rise amid tight labor market and wage growth. Tight labor markets and negotiated wage increases lifted average base pay growth in Japan to approximately 2%-3% year-on-year in recent wage rounds; hospitality and retail segments often see higher effective wage inflation due to hourly pay competition. For Tsuruha, labor represents a significant portion of operating costs - a 2% rise in average hourly wage across ~25,000 store-level employees can translate into tens of millions of yen in annual incremental payroll expense, accelerating automation and staffing mix initiatives.

Currency volatility affects imported raw material pricing. The JPY/USD exchange rate fluctuated broadly (e.g., ~¥110-¥155 per USD in 2022-2024 episodes). A weaker yen raises the JPY cost of imported OTC medicines, cosmetics, and packaging materials. Hedging can mitigate but not eliminate short-term P&L exposure; a 10% depreciation in the yen versus the USD on a JPY 20 billion annual import bill increases cost of goods sold by ~JPY 2 billion before mitigation.

Indicator (2023-24) Range / Value Direct Impact on Tsuruha
Short-term JPY interest rate ~0.0% to 0.5% Higher corporate borrowing costs; increased store-level financing expenses
Japan CPI (headline) ~2%-3% YoY Compressed household real income; shift to private labels
GDP growth ~0.5%-1.5% YoY Limited same-store-sales growth; selective store openings
Wage growth (average) ~2%-3% YoY Higher payroll expense; increased automation spending
JPY/USD exchange rate volatility ~¥110-¥155 per USD Significant import cost variability; hedging and price adjustments
  • Operational responses: price optimization, private-label expansion (higher-margin SKUs), procurement diversification, and selective FX hedging.
  • Capital allocation: defer marginal new-store openings, prioritize refurbishments and M&A with better immediate cash returns.
  • Cost control: scheduling efficiency, labor productivity programs, and investment in self-checkout/automation to offset wage inflation.

Tsuruha Holdings Inc. (3391.T) - PESTLE Analysis: Social

Japan's demographic structure and evolving consumer behaviors significantly shape Tsuruha Holdings' strategic priorities. The share of population aged 65+ in Japan is approximately 29% (2023), creating sustained demand for medications, chronic care products, home healthcare devices, and consultation services tailored to elderly customers. Tsuruha's store network - approximately 1,900 locations nationwide (company disclosures, 2023-2024) - positions it to capture this demand through localized elderly-focused offerings and delivery/remote-care services.

Urbanization and changing settlement patterns concentrate competition in metropolitan centers while creating opportunities in compact-store formats. Japan's urban population is roughly 90-92%, with Tokyo still accounting for a disproportionate share of retail density. Tsuruha faces intense competition in dense urban zones from rival drugstore chains and convenience retailers, requiring smaller-format stores (typically 30-100 m²) optimized for high-turnover health and beauty SKUs, faster replenishment cycles, and integrated digital payment/loyalty systems.

Health-conscious trends are driving category growth across OTC, supplements, functional foods, and beauty-with-health products. Market indicators show the domestic functional-foods and supplement market exceeding ¥1.2 trillion annually (Ministry of Health/industry estimates, recent years). Tsuruha's in-store health services (blood-pressure checks, medication counseling, nutritional advice) and expanded private-label wellness ranges can increase average basket size - typical drugstore basket increases of 5-15% when health services are offered have been reported in retail case studies.

Labor-market constraints and workforce demographics force operational adaptation. Japan's labor participation is high but sector-specific shortages persist: retail staffing vacancy rates in non-food retail sectors have risen, with part-time labor shortages and an aging workforce driving increased wage pressure. Tsuruha must diversify recruitment (female employment, seniors, foreign workers), invest in automation (self-checkout, inventory robotics), and enhance staff training for clinical and counseling roles. Estimated personnel costs for drugstore chains have risen by mid-single digits year-on-year in recent reporting periods, compressing gross margin unless offset by productivity gains.

Social convergence of retail, food, and digital health is reshaping customer expectations. Consumers increasingly expect multi-category convenience (pharmacy, food, daily goods) and seamless integration with health and lifestyle apps. Tsuruha's strategic responses include in-store grocery assortments, partnerships with meal/food-delivery and telehealth providers, and mobile app functionality for prescriptions, loyalty points, and health monitoring. Digital engagement can materially influence KPIs: app users typically exhibit higher visit frequency (estimates +20-40%) and greater lifetime value.

Key sociological elements, estimated impacts, and operational implications for Tsuruha are summarized below.

Social Factor Quantitative Snapshot Direct Impact on Tsuruha Strategic Implication
Aging Population 65+ ≈ 29% of population (2023) Increased chronic medication demand; higher service needs; rising home-care product sales Expand elderly-focused services, home delivery, medication management programs
Urbanization Urban population ≈ 90-92%; high retail density in metro areas Intense competition in cities; need for smaller store footprints and rapid stock turnover Deploy compact-format stores, hyperlocal assortments, optimize inventory turnover
Health-Conscious Consumers Functional food/supplement market > ¥1.2T; rising wellness spend Higher demand for OTC, supplements, beauty-health hybrids Broaden private-label wellness range; enhance in-store health services
Labor Shortages & Workforce Aging Retail staffing pressure; rising personnel costs (mid-single digit growth) Operational cost increases; staffing mix challenges Invest in automation, staff training, diverse hiring (seniors, women, foreign workers)
Service Integration & Digitalization Mobile app users show +20-40% visit frequency (industry estimates) Customer expectations for combined food-health-digital services Integrate apps, telehealth, food/last-mile partnerships to raise basket and retention

Practical near-term social priorities for Tsuruha include:

  • Scaling prescription delivery and medication adherence programs to serve the 65+ segment and reduce clinic visit burden.
  • Designing micro-store formats and SKU rationalization for urban catchments to maximize sales per square meter.
  • Expanding private-label and curated wellness assortments aligned to functional-health trends, with targeted merchandising and pricing strategies.
  • Implementing workforce strategies: flexible scheduling, skills certification for pharmacy staff, robotics in logistics to offset rising wage costs.
  • Pursuing digital partnerships (telemedicine, meal-delivery, health-data sharing) to embed Tsuruha into daily health routines and drive higher customer lifetime value.

Tsuruha Holdings Inc. (3391.T) - PESTLE Analysis: Technological

Digital transformation at Tsuruha has accelerated omnichannel integration, combining brick-and-mortar sales across ~1,800 stores (FY2024) with online marketplaces and a proprietary e-commerce platform. Investment in POS modernization and customer data platforms (CDP) - capital expenditure ~¥6.2bn in FY2023 on IT systems across the group - enables personalized promotions, loyalty integration (Tsuruha Club > 15 million members), and real-time sales analytics to optimize assortment and pricing.

Key digital transformation metrics:

Metric Value / Source Impact
Stores integrated with ePOS and CDP ~1,800 stores (FY2024) Unified customer view; faster promotions
Tsuruha Club members >15,000,000 Data for personalized marketing
IT CAPEX ¥6.2bn (FY2023) System upgrades and digital projects
Online sales share Estimated 6-10% of revenue (growing) Expanding non-store revenue

E-commerce growth combined with cashless and mobile payment adoption drives convenience and higher basket sizes. Japan's cashless transaction rate rose to ~40% (2023), and Tsuruha's support for major QR codes, mobile wallets, and in-app payments reduces friction. The company's marketplace partnerships and click-and-collect services have improved order fulfillment speed, increasing average online order value by an estimated 12-18% versus in-store baskets.

  • Payment options: QR, NFC, credit, BNPL pilots
  • Fulfillment channels: Home delivery, curbside pickup, locker partners
  • Omnichannel KPIs: conversion lift 1.2-1.5x; repeat rate +8-12%

AI-driven logistics and inventory management are deployed to reduce stockouts and optimize shelf availability. Machine learning demand-forecasting models use POS, seasonality, weather, regional epidemiological data, and promotional calendars to achieve forecast accuracy improvements of 10-25%. Autonomous replenishment systems and hub-and-spoke distribution reduce lead times and safety stock, cutting excess inventory days by an estimated 6-10 days for fast-moving SKUs.

Logistics Component Technology Measured Outcome
Demand forecasting ML models (time-series + external data) Forecast accuracy +10-25%
Replenishment Automated reorder thresholds Stockouts reduced 20-35%
Distribution Hub-and-spoke routing, route optimization Delivery efficiency +15-22%
Inventory days Safety stock optimization Inventory days reduced 6-10 days

Telemedicine integration is emerging within Tsuruha's health services strategy through partnerships with digital clinics and licensed remote consultation platforms. Digital prescriptions (e-prescriptions) and pharmacy coordination enable same-day medication fulfillment via in-store pickup or courier. Pilot programs report patient-to-pharmacy digital prescription routing increased prescription fill rates by ~12% and reduced dispensing turnaround by 20-30% in participating stores.

  • Services: remote consultation referrals, e-prescription acceptance
  • Operational effect: shortened time-to-treatment, improved adherence
  • Regulatory consideration: compliance with Japan's e-prescription and telemedicine guidelines

Integration of wearable health data and smart-shelf technologies supports proactive care and targeted merchandising. Wearable devices (step counts, sleep, heart rate) and health apps, when consented, feed anonymized insights into demand signals for vitamins, OTC medications, and preventive products. Smart shelves with weight and RFID sensors enable real-time stock visibility, shrink reduction, and automated alerts for replenishment, improving on-shelf availability by 8-15%.

Technology Application Business Benefit
Wearable data integration Personalized recommendations, demand signals Higher relevance; potential AOV uplift 5-12%
Smart shelves (RFID/weight) Real-time stock and shrink detection On-shelf availability +8-15%; shrink down 5-10%
In-store kiosks/health check terminals BP, glucose checks, symptom triage Cross-sell increase; service revenue growth

Tsuruha Holdings Inc. (3391.T) - PESTLE Analysis: Legal

Stricter pharmaceutical safety and traceability requirements: Japan's Pharmaceuticals and Medical Devices Agency (PMDA) and revised Pharmaceutical and Medical Device Act (PMD Act) have increased obligations for pharmacy chains. Tsuruha, which operates ~1,600 stores (FY2024), must implement serialized tracking for prescription medicines, maintain batch-level traceability, and comply with adverse event reporting timelines (typically within 15 days for serious events). Non-compliance fines can reach ¥1 million-¥100 million per incident and administrative suspension of dispensing privileges. Implementation requires integration with pharmacy management systems, supply-chain data exchange standards and staff training across all store locations.

RequirementKey ObligationTypical Deadline / ThresholdEstimated One-time IT Cost (¥ millions)
Serialization & TraceabilityUnique identifiers on prescription packs, end-to-end trackingImmediate; phased compliance completed by large chains within 24 months150-400
Adverse Event ReportingSubmission to PMDA within 15 days for serious events15 calendar days10-50
Pharmacist VerificationEnhanced documentation and audit trails for dispensingOngoing; documented per-dispense records30-80

Work-Style Reform raises overtime, staffing and leave obligations: The 2019 Work Style Reform laws and subsequent labor rule updates cap overtime and require stricter recordkeeping. For retail pharmacies, limits on overtime (e.g., 45-100 hours/month depending on exemptions) force hiring of additional pharmacists and staff. Tsuruha's current headcount of pharmacists and part-time staff must be adjusted to avoid overtime penalties and collective bargaining issues. Potential exposure includes labor inspections, retroactive wage claims and fines up to ¥300,000 per violation or criminal sanctions for repeated breaches.

  • Overtime caps: statutory overtime limits generally 45 hours/month standard; special clauses allow up to 100 hours/month but trigger employer obligations.
  • Mandatory paid leave: employers must ensure at least 5 days of annual leave for employees who accrue 10+ days.
  • Recordkeeping: digital time-and-attendance systems required; audit trail retention typically 3-5 years.

Stronger data privacy rules heighten cybersecurity and reporting: Amendments to the Act on the Protection of Personal Information (APPI) and tougher guidance on health data impose stricter consent, purpose-limitation and cross-border transfer controls. Pharmacies process sensitive personal health information (PHI) for prescriptions and loyalty programs - Tsuruha must maintain data breach detection, encryption, third-party vendor audits and mandatory notification to the Personal Information Protection Commission (PPC) and affected individuals within 72 hours of a serious breach. Financial exposure from breaches includes regulatory fines (up to 3% of annual turnover in some jurisdictions), civil claims, and reputational loss; for a retailer with ¥600 billion revenue (example FY), 3% equates to ¥18 billion potential maximum.

Data CategoryCommon Use at TsuruhaRequired ControlsEstimated Annual Compliance Cost (¥ millions)
Prescription PHIDispensing records, diagnoses, dosingEncryption at rest/in transit, access control, retention policies50-200
Loyalty Program DataPurchase history, contact infoConsent management, pseudonymization20-80
Vendor/CloudSupply chain & POS systemsVendor risk assessments, contractual clauses10-40

Plastic reduction laws compel sustainable packaging and waste policy: National and municipal regulations targeting single-use plastics require retail chains to reduce plastic bag use, shift to biodegradable materials and improve recycling. Japanese government targets and local ordinances impose fees or bans on certain disposable items and mandate consumer communication. Tsuruha must redesign packaging for OTC and private-label products, implement in-store bag-charge policies, and track waste reduction metrics. Estimated transition cost for packaging redesign and supply chain adjustments ranges from ¥200-700 million upfront, with ongoing savings or cost shifts depending on material prices.

  • Regulatory drivers: national targets to reduce single-use plastic by 25-50% by 2030 in many municipalities.
  • Operational impacts: SKU redesign, supplier renegotiation, point-of-sale system updates for bag fees.
  • Performance metrics: % reduction in plastic weight per SKU, recycling rate, consumer uptake of reusable bags.

Compliance costs rise with centralized tracking for dispensing: Centralized electronic prescription and dispensing tracking systems (regional health initiatives and insurer requirements) demand interoperable IT platforms, secure APIs, and real-time reporting. For a company dispensing millions of prescriptions annually (e.g., 20 million+ Rx per year across a large chain), scaling electronic tracking increases capital expenditure (CAPEX) and operating expenditure (OPEX). Estimated cumulative costs include ¥500-1,200 million CAPEX for system development and ¥100-300 million annual OPEX for maintenance, certification and audit. Legal liability expands where centralized records reveal dispensing errors, requiring strengthened internal controls, compliance officers, and higher professional indemnity insurance premiums (estimated increase 10-40% depending on claims history).

ItemScale / MetricEstimated Cost Impact (¥ millions)Regulatory Outcome
Centralized Prescription Tracking20M Rx/yearCAPEX 500-1,200; OPEX 100-300/yrMandatory reporting; auditability
Compliance StaffingCentralized compliance team 5-15 FTEsAnnual payroll 30-90Faster incident response; reduced penalty risk
Insurance PremiumsProfessional indemnityPremium increase 10-40% (depending on claims)Financial risk transfer

Tsuruha Holdings Inc. (3391.T) - PESTLE Analysis: Environmental

Ambitious carbon reduction targets drive energy and solar investments. Tsuruha has committed to long‑term greenhouse gas (GHG) reductions aligned with national and sectoral goals, targeting net‑zero by 2050 with interim targets of a 46% absolute reduction in Scope 1 and 2 emissions by 2030 vs FY2019, and a 20-30% reduction in overall value‑chain (Scope 3) intensity by 2030. Capital expenditure priorities reflect this: JPY 10-15 billion allocated to energy efficiency and renewable installations across FY2024-FY2026. Since FY2020, rooftop and carport solar installations across stores and distribution centers have generated approximately 12 GWh/year (≈¥200 million annual avoided energy cost), with a target of 50 GWh/year by 2030.

MetricBaseline (FY2019)Current (FY2023)Target (2030)
Scope 1 & 2 emissions (tCO2e)150,000120,00082,500 (-46%)
Renewable generation (GWh/year)21250
Energy CAPEX (FY24-26, JPY bn)--10-15
Energy intensity (kWh/store/month)5,2004,6003,800

Waste reduction and recycling programs reduce landfill impact. Tsuruha operates in‑store recycling points for plastic film, PET bottles and empty cosmetic containers, and implements back‑haul packaging recovery from distribution centers. The company reports a corporate waste diversion rate of 78% in FY2023, up from 62% in FY2018, and targets a 90% diversion rate by 2030. Initiatives include lightweight packaging redesign, bulk refill pilots across 200 pilot stores, and supplier take‑back schemes for oversized cardboard and plastic pallets.

  • Current diversion rate: 78% (FY2023)
  • Goal: 90% diversion by 2030
  • Refill pilot stores: 200 (FY2024)
  • Packaging weight reduction target: -15% average by 2028 vs 2022

Sustainable sourcing requires certified palm oil and supplier audits. Procurement policies prioritize RSPO‑certified palm oil for private‑label cosmetics and household products; 65% of private‑label products used certified palm oil in FY2023, with a target of 100% by 2027. Supplier sustainability audits (environmental & labor) cover 80% of Tier 1 suppliers by spend; remediation plans are mandatory for non‑conformances. Traceability initiatives extend to top 200 SKUs representing 70% of private‑label spend, with digital traceability pilots and third‑party verification.

Sourcing KPIFY2020FY2023Target
Private‑label palm oil certified (%)28%65%100% by 2027
Tier 1 suppliers audited (%)45%80%95% by 2026
Top SKU traceability coverage (%)12%70%90% by 2028

Climate risk informs site selection and disaster resilience. Tsuruha's store network planning and new DC siting integrate flood, typhoon, seismic and landslide hazard data. Recent changes to criteria include a higher elevation threshold in flood‑prone regions, reinforced glazing and elevated electrical systems for new and refurbished stores, and backup generator capacity scaled to critical stores. Business continuity planning estimates that improving resilience in the top 150 high‑risk stores reduces projected annualized climate disruption losses by ~40% (modelled from historical typhoon/flood events).

  • High‑risk stores retrofitted (FY2022-24): 150
  • Estimated reduction in annualized disruption losses: ~40%
  • Critical stores with backup power: 1,200
  • Average downtime reduction per major event: from 5.2 days to 2.1 days

Water footprint tracking supports long‑term environmental governance. Tsuruha monitors water consumption at stores, pharmacies and distribution centers; corporate water use was ~1.8 million m3 in FY2023 (≈3,800 m3/store/year average), with a 2030 target to reduce water intensity by 20% vs FY2022 through low‑flow fittings, leak detection, and HVAC optimization. High‑risk watershed assessments for 60 distribution centers guide local water stewardship actions, and water‑use KPIs are integrated into executive sustainability-linked remuneration metrics.

Water KPIFY2021FY20232030 Target
Total corporate water use (m3)1,950,0001,800,000≤1,440,000 (-20% intensity)
Average water use per store (m3/year)4,1003,8003,040
Distribution centers with watershed plans1060All DCs by 2028


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.